Medivir AB (publ)
MVRBF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $429,212 | $591,918 | $303,864 | $609,613 |
| - Cash | $6,448 | $14,690 | $14,038 | $34,300 |
| + Debt | $15,512 | $14,018 | $16,488 | $43,882 |
| Enterprise Value | $438,276 | $591,246 | $306,314 | $619,195 |
| Revenue | $4,408 | $25,538 | $13,948 | $8,724 |
| % Growth | -82.7% | 83.1% | 59.9% | – |
| Gross Profit | $4,408 | $25,538 | $13,948 | $8,724 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$85,266 | -$59,034 | -$37,643 | -$114,933 |
| % Margin | -1,934.3% | -231.2% | -269.9% | -1,317.4% |
| Net Income | -$88,765 | -$63,125 | -$42,620 | -$123,440 |
| % Margin | -2,013.7% | -247.2% | -305.6% | -1,414.9% |
| EPS Diluted | -1.59 | -1.2 | -1.44 | -4.17 |
| % Growth | -32.5% | 16.7% | 65.5% | – |
| Operating Cash Flow | -$101,820 | -$48,734 | -$58,053 | -$148,255 |
| Capital Expenditures | -$382 | $0 | -$2,684 | -$1,436 |
| Free Cash Flow | -$102,202 | -$48,734 | -$60,737 | -$149,691 |